Auristatin mit einem Heilmittel bindenden Konjugat
European patent · EP2842575 · Deleted
Register entry
- Publication number
- EP2842575
- Application number
- EP14182732
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Mar 18, 2009
- Published
- Mar 4, 2015
- Granted
- Sep 27, 2017
- Deleted
- Oct 24, 2025
- Reason
- Annual fee unpaid
- IPC classes
- A61K 47/65 (2017.01)A61K 47/68 (2017.01)C07K 5/02 (2006.01)A61K 38/00 (2006.01)
- Priority
- US 37705 P 18.03.2008US 44431 P 11.04.2008
- Divided from
- EP09721267
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 24, 2025
Deleted, fee unpaid
- Status of protective title
- Active → Cancelled
- Cancellation date
- 24.10.2025
- Cause for cancellation
- Non-payment of renewal fee
Published in Swissreg on 24.10.2025
- Apr 2, 2024
Change
Published in Swissreg on 02.04.2024
- Apr 1, 2023
Change
Published in Swissreg on 01.04.2023
- Jun 1, 2021
Address changed
- Owner
- Seattle Genetics, Inc., 21823 30th Drive, S.E., Bothell, WA 98021, USA → Seagen Inc., 21823 30th Drive, S.E., Bothell, WA 98021, USA
Published in Swissreg on 01.06.2021
- Sep 27, 2017
Granted
Published in Swissreg on 27.09.2017
Parties
Inventor
Senter, Peter
Bothell, WA 98021, US
Doronina, Svetlana
Bothell, WA 98021, US
Bovee, Timothy
Bothell, WA 98021, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.